معرفی
Kat Petrilli is a researcher specializing in the neuropsychopharmacological effects of cannabis, particularly focusing on developmental differences between adolescents and adults. Her work contributes to UN Sustainable Development Goals related to mental health and well-being. Active in the Addiction and Mental Health Group (AIM), her research explores cannabis use disorder, brain network changes, and behavioral outcomes.
Key research interests include: Cannabis neurobiology, adolescent vulnerability to cannabis effects, resting-state functional connectivity analysis, and neuropsychiatric symptomology associated with cannabis use. Her studies employ advanced neuroimaging techniques and randomized controlled trials to assess acute and chronic effects of cannabis compounds like THC and CBD.
Recent publications emphasize longitudinal studies on cannabis use disorder symptom persistence in adolescents, attentional bias mechanisms, and neuroimaging correlates of cannabis exposure. Her work has been widely cited and covered by news outlets, demonstrating significant societal impact in addiction research.
